Biogen provides information on upcoming Spinraza EU label

In response to our request, Biogen has provided us with information and addressed our questions and concerns regarding the upcoming SPINRAZA (nusinersen) EU label (Prescribing information and Package Leaflet) update that will include information on the potential risk of hydrocephalus. All medicines are evaluated for the benefit they provide to patients as well as the … Continue reading Biogen provides information on upcoming Spinraza EU label